iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Shares Down 0.6% – Should You Sell?

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN)’s stock price were down 0.6% during mid-day trading on Monday . The company traded as low as $33.11 and last traded at $33.11. Approximately 1,558 shares traded hands during mid-day trading, a decline of 19% from the average daily volume of 1,917 shares. The stock had previously closed at $33.31.

iShares Neuroscience and Healthcare ETF Trading Down 0.6%

The stock has a market cap of $4.97 million, a price-to-earnings ratio of 15.61 and a beta of 0.93. The stock has a 50-day moving average price of $32.04 and a two-hundred day moving average price of $30.86.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.